Analyst IMS Investment Management Services Ltd.
Position in MRK — Merck & Co., Inc.
CIK 1634208
Tel-aviv, L3
Position in MRK
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$1,155,857
-$140,748 QoQ
Shares Held
8,995
-16.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#1,997
of 3,769 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Analyst IMS Investment Management Services Ltd. holds $26,750,918 across 7 Drug Manufacturers - General names. MRK ranks #4 (4.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVO |
Novo Nordisk A S
|
410,770 | $19,692,313 | |
| 2 | LLY |
ELI LILLY & Co
|
2,047 | $2,455,233 | |
| 3 | JNJ |
Johnson & Johnson
|
8,024 | $2,037,854 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
8,995 | $1,155,857 | |
| 5 | ABBV |
AbbVie Inc.
|
3,869 | $973,595 | |
| 6 | SNY |
Sanofi
|
5,208 | $222,173 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
1,693 | $213,893 |
All Filings in MRK
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,155,857 | 8,995 | Shares | Defined | 2026-07-29 | |
| 2026-03-31 | $1,296,605 | 10,779 | Shares | Defined | 2026-04-23 | |
| 2025-12-31 | $1,083,966 | 10,298 | Shares | Defined | 2026-01-20 | |
| 2025-09-30 | $215,280 | 2,565 | Shares | Defined | 2025-10-20 | |
| 2025-06-30 | $203,045 | 2,565 | Shares | Defined | 2025-08-04 | |
| 2025-03-31 | $230,234 | 2,565 | Shares | Defined | 2025-04-21 | |
| 2024-12-31 | $850,553 | 8,550 | Shares | Defined | 2025-02-10 | |
| 2024-09-30 | $1,248,818 | 10,997 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,002,656 | 8,099 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $621,615 | 4,711 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $245,295 | 2,250 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $231,637 | 2,250 | Shares | Defined | 2023-10-31 | |
| 2023-06-30 | $259,627 | 2,250 | Shares | Defined | 2023-07-31 | |
| 2023-03-31 | $239,377 | 2,250 | Shares | Defined | 2023-05-02 | |
| 2022-12-31 | $249,637 | 2,250 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $314,338 | 3,650 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $537,902 | 5,900 | Shares | Defined | 2022-07-25 | |
| 2022-03-31 | $315,892 | 3,850 | Shares | Defined | 2022-04-28 | |
| 2021-12-31 | $521,918 | 6,810 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $511,498 | 6,810 | Shares | Defined | 2021-11-16 | |
| 2021-06-30 | $510,948 | 6,570 | Shares | Defined | 2021-08-05 | |
| 2021-03-31 | $471,790 | 6,120 | Shares | Defined | 2021-05-06 | |
| No filing history on record for this holder in this stock. | ||||||